Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.72252 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.70674 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.70184 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.63151 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.68957 | 32 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.84488 | 34 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.70925 | 29 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.68806 | 31 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.68359 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.68699 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.69608 | 31 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.69506 | 32 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.7048 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.69702 | 31 |